Health TrialsbyHealthPanel

The Added Value of Bone Microstructure Assessment in the Management of Osteoporotic Bone

ConditionOsteoporosis
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorRobert Jones and Agnes Hunt Orthopaedic and District NHS Trust

About this trial

1. To assess the clinical utility of trabecular bone score (TBS) on fracture risk prediction including the new version (TBS V4) and future TBS versions at the spine and hip. 2. To assess the clinical utility of TBS software as a potential treatment outcome: sensitivity to change over time and following osteoporosis therapy. 3. To compare TBS to other imaging modalities of bone structure such as quantitative computed tomography (QCT) in fracture risk prediction and response to osteoporosis therapy.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Has had a DEXA scan

Disqualifiers

Unable to complete DEXA scan

Trial population

Adult female and male patients over the age of 18.

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

  • Trabecular bone score software

    Other intervention

    To assess the clinical utility of trabecular bone score (TBS) on fracture risk prediction including the new version (TBS V4) and future TBS versions at the spine and hip.

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

To assess the newest version of TBS software on fracture prediction

Time frame
10 years

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: